Nearly half of all women eligible for breast cancer screening have dense breast tissue, which both increases cancer risk and makes tumors harder to spot on standard mammograms. For active duty military women, this challenge carries urgent implications: research shows they experience significantly higher breast cancer rates than the general population, yet federal health systems like TRICARE and the Veterans Health Administration don't cover supplemental screening options that could catch cancers earlier .

Why Does Dense Breast Tissue Make Cancer Detection So Difficult?

Dense breast tissue appears white on mammogram images, just like tumors do. This creates a visual masking effect that can hide cancers in plain sight. When a tumor blends into the background of dense tissue, radiologists may miss it entirely, or the cancer progresses further before detection. Research conducted at Walter Reed National Military Medical Center found that active duty women ages 40 to 59 experience significantly higher rates of breast cancer compared to women in the general population . Because dense breast tissue obscures tumors on standard mammograms, cancers in these patients are more likely to be detected at later stages, potentially affecting treatment outcomes and military readiness.

"Breast cancers in women with dense breasts often present later because they are harder to detect with standard screening. For active duty women, delayed diagnosis can have serious consequences not only for individual health but also for readiness across the force," explained Army Col. (Dr.) Danielle Holt, an associate professor of surgery at Uniformed Services University.

Army Col. (Dr.) Danielle Holt, Associate Professor of Surgery at Uniformed Services University

Dr. Holt published an editorial in the Journal of the American Medical Association (JAMA) in March 2026 calling attention to this screening gap. Her work highlights how current insurance coverage policies fail to address the needs of women with dense breast tissue, particularly those serving in the military .

What Advanced Screening Options Are Available But Not Covered?

Breast MRI (magnetic resonance imaging) is significantly more sensitive than mammography and detects cancers at higher rates, particularly in women with extremely dense breast tissue. However, insurance coverage for MRI screening remains limited to a small subset of patients. The disconnect between clinical evidence and coverage decisions creates real barriers for patients and physicians alike .

Congress recognized the need for improved screening through the SERVICE Act of 2022, which acknowledges that women who have served in the military may qualify for additional breast cancer risk assessment under National Comprehensive Cancer Network (NCCN) guidelines. However, while 39 states have enacted laws requiring supplemental screening for women with dense breast tissue, these mandates do not apply to federal health systems such as TRICARE and the Veterans Health Administration, which operate under separate federal authorities .

How Can Physicians Better Tailor Screening for Individual Patients?

• Risk Stratification Tools: Artificial intelligence-enabled diagnostic tools and risk prediction models can help clinicians identify which patients would benefit most from supplemental imaging based on their individual risk profile, rather than applying one-size-fits-all coverage policies.
• Precision Screening Approach: Instead of universal MRI screening for all women with dense breasts, a more targeted strategy uses advanced risk assessment to guide supplemental imaging decisions, reducing unnecessary biopsies and false positives while catching cancers earlier.
• Physician-Directed Coverage: Insurers should support physician-recommended supplemental imaging rather than relying on arbitrary criteria, allowing doctors to make screening decisions based on clinical judgment and modern risk assessment tools.

"Precision screening, guided by clinical judgment and modern risk stratification tools, offers a more effective approach than rigid coverage policies. Insurers should support physician-directed supplemental imaging rather than relying on arbitrary criteria," Holt wrote in her editorial.

Army Col. (Dr.) Danielle Holt, Associate Professor of Surgery at Uniformed Services University

Dr. Holt acknowledges that universal MRI screening is impractical because of potential drawbacks, including false positives and unnecessary biopsies. However, she argues that the current system of limited coverage creates equally problematic outcomes by delaying diagnosis in women who would clearly benefit from advanced imaging .

For the Military Health System, the issue extends beyond individual patient care. Earlier detection and more accurate screening strategies could improve health outcomes for service members while reducing the readiness impacts associated with advanced-stage cancer diagnoses. Holt's editorial highlights opportunities to better align screening coverage decisions with evolving clinical evidence and enable physicians to provide the most appropriate screening for patients with dense breast tissue .